Mutations in BRCA1 do not appear to contribute significantly to the risk of prostate cancer progression, according to DNA ...
We recently compiled a list of the Jim Cramer Remembers COVID-19 & Discusses These 11 Stocks. In this article, we are going ...
Merck & Co. has won U.S. Food and Drug Administration priority review for its application seeking expanded use of its blockbuster cancer drug Keytruda in certain patients with head and neck cancer.
Eli Lilly and Company, Johnson & Johnson, Pfizer, Merck & Co., Inc., and Novo Nordisk A/S are the five Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. These ...
Merck Life Science opens formulation & technology centre in Turbhe, Navi Mumbai: Our Bureau, Bengaluru Tuesday, February 25, ...
Excerpts from recent editorials in the United States and abroad: ___ Feb. 20 The Washington Post says Musk's mass firings are backfiring President Donald Trump and Elon Musk have been rapidly firing ...
Ligand originated, structured, and invested $50 million and led a syndicate of co-investors who invested $25 million in ...
Merck & Co. is facing a class action lawsuit over Gardasil sales projections. Learn how to recover losses with Levi & ...
Keytruda demonstrated a statistically significant and clinically meaningful improvement in event-free survival and major ...
According to the average brokerage recommendation (ABR), one should invest in Merck (MRK). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results